No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet

Diabetes, Obesity and Metabolism

Volumn 9, Issue 4, 2007, Pages 566-574

  Due, Anette ^a   Flint, A ^b   Eriksen, G ^a   Moller B ^a   Raben, A ^b   Hansen, J B ^b   Astrup, A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Adverse effects; Appetite; Body fat; Diazoxide; Hyperinsulinaema; Obesity

Indexed keywords

C PEPTIDE; DIAZOXIDE; GLUCOSE; INSULIN; PLACEBO;

ADULT; APPETITE; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG TARGETING; EDEMA; ENERGY EXPENDITURE; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPERINSULINEMIA; INDIGESTION; INSULIN RELEASE; INSULIN RESISTANCE; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PARALLEL DESIGN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TEST MEAL; TREATMENT DURATION; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

EID: 34347380139     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00645.x     Document Type: Article

References (26)

1. Jeanrenaud B. Hyperinsulinemia in obesity syndromes: Its metabolic consequences and possible etiology. Metabolism 1978; 27: 1881-1892.
2. Kaiyala KJ, Woods SC, Schwartz MW. New model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 1995; 62: 1123S-1134S.
3. Sigal RJ, El-Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH. Acute postchallenge hyperinsulinemia predicts weight gain: A prospective study. Diabetes 1997; 46: 1025-1029.
4. Valdez R, Mitchell BD, Haffner SM et al. Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study. Int J Obes Relat Metab Disord 1994; 18: 85-91.
5. Hoag S, Marshall JA, Jones RH, Hamman RF. High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: The San Luis Valley Diabetes Study. Int J Obes Relat Metab Disord 1995; 19: 175-180.
6. Swinburn BA, Nyomba BL, Saad MF et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168-173.
7. Eckel RH. Insulin resistance: An adaptation for weight maintenance. Lancet 1992; 340: 1452-1453.
8. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997; 46: 1341-1345.
9. Caro JF, Dohm LG, Pories WJ, Sinha MK. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev 1989; 5: 665-689.
10. Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J. Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 1993; 133: 705-712.
11. Alemzadeh R, Jacobs W, Pitukcheewanont P. Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 1996; 45: 334-341.
12. Alemzadeh R, Holshouser S. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats. Endocrinology 1999; 140: 3197-3202.
13. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE. Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 1998; 83: 1911-1915.
14. World Health Organisation. Energy and protein requirements. Report of a joint FAO/WHO/UNU Expert Consultation. World Health Organ Tech Rep Ser 1985; 724: 1-206.
15. Astrup A, Pedersen U, Toubro S, Vedelspang V. Spis for livet. Kostomlægning til et bedre liv 2002: 1-112. Aschehoug.
16. National Food Agency of Denmark. DANKOST 2000 Package. Søborg, Denmark. Dansk Catering Centre 2000.
17. Barker Norton Pharmaceuticals Inc. Product Information. 1995.
18. Heitmann BL. Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int J Obes 1990; 14: 789-802.
19. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24: 38-48.
20. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
21. FAO/WHO. The Role of the Glycemic Index in Food Choice. I: Carbohydrates in Human Nutrition. Report of a joint FAO/WHO expert consultation FAO food and nutrition Paper -66. Kap. 4, 1998.
22. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332: 621-628.
23. Prentice AM, Goldberg GR, Jebb SA, Black AE, Murgatroyd PR, Diaz EO. Physiological responses to slimming. Proc Nutr Soc 1991; 50: 441-458.
24. Yang YJ, Youn JH, Bergman RN. Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 1987; 253: E595-E602.
25. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 2003; 88: 1019-1023.
26. Schreuder T, Karreman M, Rennings A, Ruinemans-Koerts J, Jansen M, de BH. Diazoxide-mediated insulin suppression in obese men: A dose-response study. Diabetes Obes Metab 2005; 7: 239-245.